Collaboration will extend work to prioritize valuable novel target-effector pairs, ideal for subsequent molecular glue development, including aiming at targets previously considered undruggable through...
A2 Biotherapeutics, Inc., a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies to address the high unmet needs in cancer, announced the appointment...
CVRx, Inc., a commercial-stage medical device company, announced the appointment of Kevin Hykes as the Company’s new President and Chief Executive Officer, effective February...
Collaboration leverages expertise in artificial intelligence from Genentech and NVIDIA to unlock scientific innovation and empower R&D at a scale previously unattainable in pursuit...